This role serves as a flexible program leader within the Separation Management Office (SMO), supporting the successful separation of Medtronic’s Diabetes business by driving critical operational priorities across Order-to-Cash, Procure-to-pay, Transition Services Agreement (TSA) exits, and delayed market readiness.
Base: $115,200.00 - $172,800.00; Bonus/Equity: Eligible for Medtronic Incentive Plan (MIP); Benefits: Health, Dental, vision, HSA, FSA, Life insurance, LTD, Dependent daycare, Tuition assistance, 401(k) match, PTO, Holidays, ESPP, EAP, Non-qualified Retirement Plan Supplement
Must-have
Nice-to-have
Must have unrestricted U.S. work authorization